Novavax, Inc. (VIE:NVAX)
Austria · Delayed Price · Currency is EUR 8.37
-0.19 (-2.23%)
At close: Mar 6, 2026
Novavax Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 240.63 | 530.23 | 568.51 | 1,337 | 1,515 |
Short-Term Investments | 494.45 | 392.89 | - | - | - |
Cash & Short-Term Investments | 735.08 | 923.12 | 568.51 | 1,337 | 1,515 |
Cash Growth | -20.37% | 62.38% | -57.48% | -11.76% | 113.08% |
Accounts Receivable | 106.45 | 108.29 | 297.24 | 82.38 | 454.99 |
Inventory | 11.55 | 8.75 | 41.7 | 36.68 | 8.87 |
Other Current Assets | 125.2 | 88.79 | 236.45 | 247.45 | 176.14 |
Total Current Assets | 978.28 | 1,129 | 1,144 | 1,703 | 2,155 |
Net Property, Plant & Equipment | 67.7 | 300 | 490.99 | 400.49 | 265.86 |
Goodwill | 113.46 | 107.48 | 127.45 | 126.33 | 131.48 |
Other Long-Term Assets | 17.08 | 24 | 35.16 | 28.47 | 24.29 |
Total Assets | 1,177 | 1,560 | 1,797 | 2,259 | 2,577 |
Accounts Payable | 24.58 | 41.58 | 132.61 | 216.52 | 127.05 |
Accrued Expenses | 107.17 | 211.17 | 394.67 | 591.16 | 673.73 |
Current Portion of Long-Term Debt | - | - | - | 324.88 | - |
Current Portion of Leases | 2.51 | 7.01 | 5.14 | 27.2 | 130.53 |
Unearned Revenue | 140.05 | 675.07 | 241.31 | 370.14 | 1,423 |
Other Current Liabilities | 185.65 | 219.6 | 861.41 | 930.06 | 36.06 |
Total Current Liabilities | 459.95 | 1,154 | 1,635 | 2,460 | 2,390 |
Long-Term Debt | 244.21 | 169.68 | 168.02 | 166.47 | 323.46 |
Long-Term Leases | 2.09 | 53.73 | 55.92 | 31.24 | - |
Other Long-Term Liabilities | 598.01 | 806.43 | 655.34 | 235.11 | 214.65 |
Total Long-Term Liabilities | 844.32 | 1,030 | 879.28 | 432.81 | 538.11 |
Total Liabilities | 1,304 | 2,184 | 2,514 | 2,893 | 2,928 |
Common Stock | 1.65 | 1.62 | 1.41 | 0.87 | 0.76 |
Treasury Stock | -103.02 | -95.85 | -92.27 | -90.66 | -85.1 |
Additional Paid-in Capital | 4,540 | 4,501 | 4,192 | 3,738 | 3,352 |
Accumulated Other Comprehensive Income | 2.01 | -22.56 | 2.72 | -6.38 | -1.35 |
Retained Earnings | -4,568 | -5,008 | -4,821 | -4,276 | -3,618 |
Shareholders' Equity | -127.75 | -623.84 | -716.93 | -634.08 | -351.67 |
Total Liabilities & Equity | 1,177 | 1,560 | 1,797 | 2,259 | 2,577 |
Total Debt | 248.81 | 230.42 | 229.08 | 549.78 | 453.99 |
Net Cash (Debt) | 486.27 | 692.7 | 339.42 | 787.1 | 1,061 |
Net Cash Growth | -29.80% | 104.08% | -56.88% | -25.82% | 336.56% |
Net Cash Per Share | 2.81 | 4.55 | 3.37 | 10.07 | 14.26 |
Book Value | -127.75 | -623.84 | -716.93 | -634.08 | -351.67 |
Book Value Per Share | -0.74 | -4.10 | -7.11 | -8.11 | -4.73 |
Tangible Book Value | -241.22 | -731.32 | -844.38 | -760.41 | -483.15 |
Tangible Book Value Per Share | -1.39 | -4.81 | -8.38 | -9.73 | -6.49 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.